Total Payments
$244,440
2024 Payments
$1,234
Companies
35
Transactions
566
Medicare Patients
3,591
Medicare Billing
$726,790
Payment Breakdown by Category
Other$181,117 (74.1%)
Travel$35,769 (14.6%)
Consulting$18,474 (7.6%)
Food & Beverage$8,524 (3.5%)
Education$555.20 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $181,117 | 99 | 74.1% |
| Travel and Lodging | $35,769 | 203 | 14.6% |
| Consulting Fee | $18,474 | 10 | 7.6% |
| Food and Beverage | $8,524 | 222 | 3.5% |
| Education | $555.20 | 32 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $232,730 | 400 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,635 | 6 | $0 (2024) |
| GENZYME CORPORATION | $3,753 | 9 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $341.75 | 13 | $0 (2023) |
| Amgen Inc. | $298.50 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $289.94 | 16 | $0 (2024) |
| Relypsa, Inc. | $240.73 | 9 | $0 (2019) |
| Travere Therapeutics, Inc. | $236.41 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $163.48 | 10 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $160.75 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,234 | 48 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($274.00) |
| 2023 | $966.18 | 36 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($274.00) |
| 2022 | $10,238 | 24 | Otsuka America Pharmaceutical, Inc. ($9,576) |
| 2021 | $25,683 | 26 | Otsuka America Pharmaceutical, Inc. ($25,537) |
| 2020 | $44,997 | 93 | Otsuka America Pharmaceutical, Inc. ($41,330) |
| 2019 | $115,981 | 214 | Otsuka America Pharmaceutical, Inc. ($113,734) |
| 2018 | $41,158 | 89 | Otsuka America Pharmaceutical, Inc. ($40,645) |
| 2017 | $4,183 | 36 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,792) |
All Payment Transactions
566 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: NEPHROLOGY | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/24/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Nephrology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.86 | General |
| Category: NEPHROLOGY | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $41.65 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEPHROLOGY | ||||||
| 07/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 04/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $274.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 773 | 1,301 | $234,033 | $119,044 |
| 2022 | 13 | 757 | 1,564 | $280,126 | $141,240 |
| 2021 | 12 | 989 | 2,122 | $424,147 | $223,834 |
| 2020 | 13 | 1,072 | 2,411 | $524,883 | $242,672 |
Total Patients
3,591
Total Services
7,398
Medicare Billing
$726,790
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 122 | $61,000 | $33,673 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 331 | $61,235 | $29,899 | 48.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 170 | 302 | $33,220 | $18,937 | 57.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 76 | $16,340 | $7,679 | 47.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 121 | 193 | $14,475 | $7,489 | 51.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 63 | $10,395 | $5,960 | 57.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 43 | 90 | $13,500 | $4,963 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 30 | $9,450 | $4,136 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 41 | $5,945 | $2,593 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $4,655 | $2,533 | 54.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,518 | $1,138 | 32.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 20 | $300.00 | $44.00 | 14.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 27 | 183 | $91,500 | $51,643 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 322 | $59,570 | $29,332 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 155 | 331 | $36,410 | $18,598 | 51.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 137 | 352 | $26,400 | $10,810 | 40.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 61 | 116 | $17,400 | $6,767 | 38.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 13 | 26 | $11,900 | $6,231 | 52.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 49 | $10,535 | $5,267 | 50.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $9,450 | $4,754 | 50.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 35 | $5,775 | $2,651 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,731 | $2,427 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 38 | $5,510 | $2,350 | 42.7% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 15 | 49 | $735.00 | $378.27 | 51.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 14 | $210.00 | $31.02 | 14.8% |
About Dr. Thomas Mccune, MD
Dr. Thomas Mccune, MD is a Nephrology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154310050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mccune, MD has received a total of $244,440 in payments from pharmaceutical and medical device companies, with $1,234 received in 2024. These payments were reported across 566 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($181,117).
As a Medicare-enrolled provider, Mccune has provided services to 3,591 Medicare beneficiaries, totaling 7,398 services with total Medicare billing of $726,790. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Norfolk, VA
- Active Since 10/14/2005
- Last Updated 10/24/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154310050
Products in Payments
- JYNARQUE (Drug) $222,437
- SAMSCA (Drug) $6,758
- TOLVAPTAN (Drug) $1,792
- FABRAZYME (Biological) $1,108
- Veltassa (Drug) $343.59
- Velphoro (Drug) $308.33
- ACTHAR (Biological) $196.91
- LOKELMA (Drug) $175.27
- Kerendia (Drug) $163.48
- TAVNEOS (Drug) $161.44
- Auryxia (Drug) $159.45
- System One (Device) $143.91
- KRYSTEXXA (Biological) $133.96
- REXULTI (Drug) $116.26
- BENLYSTA (Biological) $107.44
- RAYALDEE (Drug) $94.58
- FABRY-DISEASE (Drug) $71.02
- LIVTENCITY (Drug) $65.95
- FARXIGA (Drug) $63.49
- Envarsus XR (Drug) $58.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Norfolk
Ramin Tolouian, M.d, M.D
Nephrology — Payments: $231,178
Nephrology $231,178
Sandeep Magoon, Md, MD
Nephrology — Payments: $189,208
Nephrology $189,208
Wei Zhao, M.d, M.D
Nephrology — Payments: $7,259
Nephrology $7,259
Dr. Harlan Rust, Md, MD
Nephrology — Payments: $6,476
Nephrology $6,476
Dr. Maxim Mirovski, Md, MD
Nephrology — Payments: $5,118
Nephrology $5,118
Dr. Suresh Rijhwani, Md, MD
Nephrology — Payments: $2,736
Nephrology $2,736